Landau Jeffrey B (CIK 0001918615)

Latest company ownership

CTMX - CytomX Therapeutics, Inc.

Role: Chief Business Officer

Shares held

7,680

Last filed at

Aug 22, 2024

Confidence Score

50.0

2025Q4

Confidence Score History

2022Q3 2025Q4

Recent buy/sell transactions

Exec date	Filing date	Company	Role	Signal	Confidence	Shares	% of shares	Under plan?	Amount (USD)
Aug 20, 2024	Aug 22, 2024	CytomX Therapeutics, Inc.	Chief Business Officer	Sell	47.5	-4,181	-3.19%	✗	$5.1K
Mar 19, 2024	Mar 21, 2024	CytomX Therapeutics, Inc.	Chief Business Officer	Sell	46.3	-6,562	-5.28%	✗	$13.7K
Dec 20, 2023	Dec 22, 2023	CytomX Therapeutics, Inc.	Chief Business Officer	Sell	47.5	-4,077	-4.14%	✗	$5.6K
Sep 20, 2023	Sep 22, 2023	CytomX Therapeutics, Inc.	Chief Business Officer	Sell	85.0	+7,131	9.27%	✗	$5.4K
Mar 16, 2023	Mar 20, 2023	CytomX Therapeutics, Inc.	CFO	Sell	47.5	-1,477	-1.88%	✗	$2.9K
Jul 19, 2022	Jul 21, 2022	CytomX Therapeutics, Inc.	Chief Business Officer	Sell	90.0	+7,044	22.46%	✗	$6K